Pharmaceutical Technology - February 2024

Pharmaceutical Technology - February 2024

Issue link: https://www.e-digitaleditions.com/i/1516147

Contents of this Issue

Navigation

Page 17 of 33

Empowering your success with scientific expertise Small Molecule Drug Substance Small molecule Drug Product Biologics Phytocannabinoids LEARN MORE Discover our comprehensive solutions ABOUT US | Eurofins CDMO Alphora Inc. - your CDMO partner for Small Molecules, Biologics & Phytocannabinoids From preclinical to commercial, our active pharmaceutical ingredient (API) drug substance and drug product services tailor solutions for complex, small molecule programs Elevate your Antibody Drug Conjugate development by leveraging our biologics capabilties and extensive experience in API & High Potent API Develop pharmaceutical-grade phytocannabinoids and reference standards via synthetic routes which are not readily produced through traditional extraction involving cannabis plants or seeds CONTACT US

Articles in this issue

Links on this page

Archives of this issue

view archives of Pharmaceutical Technology - February 2024 - Pharmaceutical Technology - February 2024